Corcept Therapeutics Incorporated
US ˙ NasdaqCM ˙ US2183521028

SecurityCORT / Corcept Therapeutics Incorporated
InstitutionSei Investments Co
Latest Disclosed Ownership94,756 shares
Latest Disclosed Value $ 3,297,515
Sei Investments Co reports 251.76% increase in ownership of CORT / Corcept Therapeutics Incorporated

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 94,756 shares of Corcept Therapeutics Incorporated (US:CORT) valued at $3,297,509 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 26,938 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 251.76% during the quarter. The current value of the position is $6,884,023 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 94,756 67,818 251.76 3,298 47.32 0.0033
2025-11-13 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 26,938 -18,741 -41.03 2,239 -33.23 0.0024
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 45,679 -111,994 -71.03 3,353 -81.39 0.0039
2025-05-14 2025-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 157,673 57,730 57.76 18,009 257.68 0.0232
2025-05-13 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 110,444 10,501 9,213 0.0100
2025-02-11 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 99,943 54,521 120.03 5,036 139.53 0.0065
2024-11-12 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 45,422 35,796 371.87 2,102 573.72 0.0027
2024-08-13 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 9,626 -52,001 -84.38 313 -79.90 0.0004
2024-05-07 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 61,627 41,600 207.72 1,552 138.77 0.0023
2024-02-14 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 20,027 -17,447 -46.56 650 -36.34 0.0010
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 37,474 20,008 114.55 1,021 163.14 0.0018
2023-08-11 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 17,466 303 1.77 389 4.58 0.0007
2023-05-12 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 17,163 2,761 19.17 372 27.05 0.0007
2023-02-10 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 14,402 -19,118 -57.03 293 -66.01 0.0007
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 33,520 18,955 130.14 859 118.02 0.0019
2022-08-15 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 14,565 427 3.02 394 7.36 0.0009
2022-05-13 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 14,138 14,138 367 0.0007
2021-05-12 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -22,822 -100.00 0 -100.00
2021-02-08 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 22,822 -24,359 -51.63 597 -27.28 0.0015
2020-12-04 2020-09-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 47,181 -29,269 -38.29 821 -36.16 0.0024
2020-11-06 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 47,181 -29,269 821 1,976.7855
2020-08-17 2020-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 76,450 -100 -0.13 1,286 41.32 0.0040
2020-08-11 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 40,968 -35,582 524 1,421.3779
2020-05-14 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 76,550 35,266 85.42 910 82.00 0.0033
2020-02-06 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 41,284 -5,998 -12.69 500 -25.15 0.0015
2019-11-12 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 47,282 -5,989 -11.24 668 12.46 0.0017
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 53,271 22,255 71.75 594 63.19 0.0019
2019-05-15 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 31,016 -21,461 -40.90 364 -51.21 0.0012
2019-02-13 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 52,477 244 0.47 746 1.91 0.0027
2018-11-08 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 52,233 40,512 345.64 732 297.83 0.0027
2018-08-03 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 11,721 -2,558 -17.91 184 -21.70 0.0006
2018-05-11 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 14,279 -5,271 -26.96 235 -33.43 0.0009
2018-02-08 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 19,550 1,988 11.32 353 4.13 0.0012
2017-11-06 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 17,562 13,614 344.83 339 621.28 0.0012
2017-07-31 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 3,948 1,035 35.53 47 46.88 0.0002
2017-05-05 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 2,913 -245 -7.76 32 39.13 0.0001
2017-02-02 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 3,158 3,158 23 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.